Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/19/2010US20100210709 Methods of Treatment of Opioid Tolerance, Physical Dependence, Pain and Addiction With Inhibitors of Certain Growth Factor Receptors
08/19/2010US20100210708 Compound profiling method
08/19/2010US20100210707 Small Activating RNA Molecules and Methods of Use
08/19/2010US20100210706 Pyrrolidinone anilines as progesterone receptor modulators
08/19/2010US20100210705 Pyrrole and Isoindole Carboxamide Derivatives as P2X7 Modulators
08/19/2010US20100210703 Anti-fungal formulation
08/19/2010US20100210702 Anti-fungal formulation
08/19/2010US20100210701 Novel Forms of Bendamustine Free Base
08/19/2010US20100210700 Methods of treatment using intravenous formulations comprising temozolomide
08/19/2010US20100210699 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
08/19/2010US20100210697 Pharmaceutical composition for treatment of cataract
08/19/2010US20100210696 5-membered heterocyclic compound
08/19/2010US20100210695 Compositions and methods for treating skin disorders
08/19/2010US20100210694 New no-donor aspirin derivatives
08/19/2010US20100210693 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/19/2010US20100210692 Methods of treatment using sirt modulators and compositions containing sirt1 modulators
08/19/2010US20100210690 N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
08/19/2010US20100210689 Therapeutic substituted chlorocyclopentanols
08/19/2010US20100210688 Novel Benzothiazolone Derivatives
08/19/2010US20100210687 Compounds which have activity at M1 receptor and their uses in medicine
08/19/2010US20100210686 Therapeutic agents useful for treating pain
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210684 Amine salt of carbostyril derivative
08/19/2010US20100210682 Repeated Dosing of TRPV1 Antagonists
08/19/2010US20100210681 Aqueous pharmaceutical composition
08/19/2010US20100210680 Tricyclic heterocyclic derivatives
08/19/2010US20100210679 Preventive and therapeutic medicament for gastroesophageal reflux disease
08/19/2010US20100210678 Tricyclic androgen receptor modulator compounds and methods
08/19/2010US20100210677 Novel compound, corresponding compositions, preparation and/or treatment methods
08/19/2010US20100210676 Chemically Modified Small Molecules
08/19/2010US20100210675 Solvent-free crystalline form of naltrexone
08/19/2010US20100210674 Spiroindolinone Derivatives
08/19/2010US20100210673 Pyrimidylaminobenzamide derivatives for systemic mastocytosis
08/19/2010US20100210672 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
08/19/2010US20100210671 Quinazolinone T-Type Calcium Channel Antagonists
08/19/2010US20100210670 Methods and compostions utiliziing quinazolinones
08/19/2010US20100210669 Crystalline form of entecavir, its preparation and the pharmaceutical composition and uses thereof
08/19/2010US20100210668 Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms
08/19/2010US20100210667 Imidazo [1, 2-c] pyrimidin-2-ylmethylpiperidines as orexin receptor antagonists
08/19/2010US20100210666 Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy
08/19/2010US20100210665 Diarylhydantoin compounds
08/19/2010US20100210664 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/19/2010US20100210663 Hybrid 2-Aminotetralin and Aryl-Substituted Piperazine Compounds and their Use in Altering CNS Activity
08/19/2010US20100210662 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
08/19/2010US20100210661 Stat3/5 activation inhibitor
08/19/2010US20100210660 Heterocyclic FXR Binding Compounds
08/19/2010US20100210659 Pyrrolidine derivatives as nk3 receptor antagonists
08/19/2010US20100210658 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
08/19/2010US20100210657 Bicyclic Benzamides of 3-or 4-Substituted 4-(Aminomethyl)-Piperidine Derivatives
08/19/2010US20100210656 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210655 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210654 Novel p2y12 receptor antagonists
08/19/2010US20100210653 Novel Compounds, Their Preparations and Use
08/19/2010US20100210651 Isoxazole-isoxazoles and isoxazole-isothiazoles
08/19/2010US20100210650 Isoxazole compound for the treatment of cancer
08/19/2010US20100210649 Pyridazinones and furan-containing compounds
08/19/2010US20100210648 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
08/19/2010US20100210647 Indole compounds as an inhibitor of cellular necrosis
08/19/2010US20100210646 2-morpholin-4-yl-pyrimidines as pi3k inhibitors
08/19/2010US20100210645 Certain Chemical Entities, Compositions and Methods
08/19/2010US20100210644 Chemical compounds
08/19/2010US20100210643 sGC STIMULATORS, sGC ACTIVATORS AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERS
08/19/2010US20100210642 Acetylenyl-pyrazolo-pyrimidine derivatives
08/19/2010US20100210641 Organic Compounds
08/19/2010US20100210640 Benzamide derivatives, their preparation and uses in medicine thereof
08/19/2010US20100210639 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h 1,3,6,9 tetraaza-fluorenes as chk1 kinase function inhibitors
08/19/2010US20100210638 Modulators of atp-binding cassette transporters
08/19/2010US20100210637 Heteroaryloxy nitrogenous saturated heterocyclic derivative
08/19/2010US20100210636 Benzoxazinone derivative
08/19/2010US20100210635 Renin inhibitors
08/19/2010US20100210634 Certain Chemical Entities, Compositions and Methods
08/19/2010US20100210633 Carboxamide compounds and their use
08/19/2010US20100210632 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
08/19/2010US20100210631 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
08/19/2010US20100210630 Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase
08/19/2010US20100210629 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
08/19/2010US20100210628 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210627 Pyrazine compounds, their use and methods of preparation
08/19/2010US20100210626 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
08/19/2010US20100210625 Novel1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands
08/19/2010US20100210624 Aryloxy- and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
08/19/2010US20100210623 Therapeutic compounds
08/19/2010US20100210622 Heterocyclic compounds and methods of use
08/19/2010US20100210621 Crystalline polymorphic form 631
08/19/2010US20100210620 Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers
08/19/2010US20100210619 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis
08/19/2010US20100210618 Piperidine/piperazine derivatives
08/19/2010US20100210617 Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase Inhibitors
08/19/2010US20100210616 Metal complexes incorporated within biodegradable nanoparticles and their use
08/19/2010US20100210615 Compositions and methods for enhancing corticosteroid delivery
08/19/2010US20100210614 Compositions and methods for enhancing corticosteroid delivery
08/19/2010US20100210613 Transdermally Absorbable Preparation
08/19/2010US20100210612 Detection of esr1 amplification in endometrium cancer and ovary cancer
08/19/2010US20100210611 Combination therapy
08/19/2010US20100210610 Organic compounds
08/19/2010US20100210609 Free of medium chain glycerides; topical delivery to skin; vehicle comprising at least two penetration enhancers such as propylene glycol, diisopropyl adipate, dimethyl isosorbide, 1,2,6-hexanetriol, and benzyl alcohol, as well as solvents and emulsifiers
08/19/2010US20100210608 Therapeutic treatment
08/19/2010US20100210607 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
08/19/2010US20100210606 Methods and reagents for the treatment of inflammatory disorders
08/19/2010US20100210605 Compositions Comprising 5-Amino-2-Hydroxybenzoic Acid and a Reducing Sugar
1 ... 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 ... 7860